Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

THE GREAT PEPTIDE DEBATE: FULL DISCUSSION Peptide bear Martin Shkreli squared off against peptide bull Max Marchione today in a back and forth on retatrutide, BPC-157, randomized controlled trials, the FDA, the pharmaceutical industry, and more. 00:00 Opening arguments 06:08 Martin on the downsides of retatrutide 10:24 Back and... show more

TBPN

1,484,881 subscribers

175,001 views • 5 months ago •via X (Twitter)

Health & Wellness Education Science & Technology

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

Dr. Alex Tatem

77,710 views • 4 months ago

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?

atlas

33,345 views • 7 months ago

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.

Dr. Alex Tatem

22,765 views • 6 months ago

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early

atlas

37,704 views • 3 months ago

BPC-157 is the peptide almost everyone starts with. Here is my full masterclass on it. 00:00 Intro and why BPC-157 01:44 What BPC-157 actually is 03:58 How it works in the body 07:32 Healing, inflammation and the brain 12:18 Who it is for and who skips it 14:20 Contraindications and cautions 15:52 Dosing tiers and timing 19:50 Cycling and time off 23:16 Pairing and the Wolverine stack 25:14 Reconstitution and injection 30:44 Troubleshooting and side effects 33:34 Legal status and FDA update 34:44 Oral vs injectable 36:20 The cancer debate 44:34 Final verdict

BPC-157 is the peptide almost everyone starts with. Here is my full masterclass on it. 00:00 Intro and why BPC-157 01:44 What BPC-157 actually is 03:58 How it works in the body 07:32 Healing, inflammation and the brain 12:18 Who it is for and who skips it 14:20 Contraindications and cautions 15:52 Dosing tiers and timing 19:50 Cycling and time off 23:16 Pairing and the Wolverine stack 25:14 Reconstitution and injection 30:44 Troubleshooting and side effects 33:34 Legal status and FDA update 34:44 Oral vs injectable 36:20 The cancer debate 44:34 Final verdict

Hunter Williams

28,559 views • 2 months ago

🚨 THE PEPTIDE GOLD RUSH @mansizzzzle - The #1 peptide substacker & founder of Chief Longevity Officer We discuss peptide culture, the supply-chain race, and how $HIMS fits in. One of the most fun + fascinating episodes I've ever done. Thank you Mansi!! 02:09 - Background on Mansi 03:45 - Inside peptide culture 06:30 - NAD+ shots and different form factors 08:20 - Peptide culture across cities 10:54 - Dubai’s longevity gold rush 12:21 - Why peptides feel a little like crypto 16:41 - Mansi’s peptide experiments 19:50 - FDA timeline for peptide reclassification 24:46 - Why supply chain wins 26:11 - The synthesis bottleneck 28:15 - China’s scale advantage 30:29 - Why Hims bought CS Bio 31:39 - State laws 33:57 - Who wins the peptide rush 36:51 - Pricing power, tariffs, and trust 41:53 - Why gray markets persist 45:01 - Peptides with real LTV 47:51 - The Flatiron Health for peptides Not financial, legal, or medical advice

🚨 THE PEPTIDE GOLD RUSH @mansizzzzle - The #1 peptide substacker & founder of Chief Longevity Officer We discuss peptide culture, the supply-chain race, and how $HIMS fits in. One of the most fun + fascinating episodes I've ever done. Thank you Mansi!! 02:09 - Background on Mansi 03:45 - Inside peptide culture 06:30 - NAD+ shots and different form factors 08:20 - Peptide culture across cities 10:54 - Dubai’s longevity gold rush 12:21 - Why peptides feel a little like crypto 16:41 - Mansi’s peptide experiments 19:50 - FDA timeline for peptide reclassification 24:46 - Why supply chain wins 26:11 - The synthesis bottleneck 28:15 - China’s scale advantage 30:29 - Why Hims bought CS Bio 31:39 - State laws 33:57 - Who wins the peptide rush 36:51 - Pricing power, tariffs, and trust 41:53 - Why gray markets persist 45:01 - Peptides with real LTV 47:51 - The Flatiron Health for peptides Not financial, legal, or medical advice

Hims House

196,571 views • 4 months ago

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending *against* the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending against the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice

Hims House

185,491 views • 2 months ago

Superpower co-founder Max Marchione says his company is in the early stages of conducting a BPC-157 clinical trial. He believes there's more to support the argument that BPC-157's benefits are not placebo effects than the argument that it doesn't work:

Superpower co-founder Max Marchione says his company is in the early stages of conducting a BPC-157 clinical trial. He believes there's more to support the argument that BPC-157's benefits are not placebo effects than the argument that it doesn't work:

TBPN

35,571 views • 5 months ago

AI will be safer than human doctors this year. I spoke to Superpower founder Max Marchione on why health is an information problem a human brain can't solve, and why half of humanity will be on a daily peptide within 10 years. 00:00 - Health Post AGI 04:04 - Healthcare Is Broken 07:14 - Execution Is The Moat 10:29 - The Tesla of Healthcare 14:23 - AI Caught a Stroke 19:45 - Apple vs OpenAI 23:23 - AI Doctors = Driverless Cars 26:02 - Truth-Seeking Medical AI 30:26 - Are Biomarkers Irrelevant? 33:37 - Doctors Can’t Think 36:18 - Peptides for All 40:19 - What Are You On?

AI will be safer than human doctors this year. I spoke to Superpower founder Max Marchione on why health is an information problem a human brain can't solve, and why half of humanity will be on a daily peptide within 10 years. 00:00 - Health Post AGI 04:04 - Healthcare Is Broken 07:14 - Execution Is The Moat 10:29 - The Tesla of Healthcare 14:23 - AI Caught a Stroke 19:45 - Apple vs OpenAI 23:23 - AI Doctors = Driverless Cars 26:02 - Truth-Seeking Medical AI 30:26 - Are Biomarkers Irrelevant? 33:37 - Doctors Can’t Think 36:18 - Peptides for All 40:19 - What Are You On?

Mgoes (bio/acc 🤖💉)

45,484 views • 1 month ago

$HIMS $LLY $NVO 🚨 BREAKING: Noom is acquiring a 503A pharmacy to prepare for the peptide boom We sat down with Geoff Cook (Noom CEO) to discuss why vertical integration is so important, how large the peptide market is going to be, and the evolving dynamics between telehealth platforms and big pharma A great episode with one of the best CEOs in the game - thanks again, Geoff! 00:00 - Why pharma needs DTC platforms 03:03 - Noom's 90% revenue growth 05:01 - Why Noom bought Tailor Made Compounding 07:29 - The case for vertical integration 08:56 - Compounded GLP-1s aren't going anywhere 16:48 - The Hims-Novo deal 19:08 - Noom's pitch to next-gen pharma 24:24 - Peptide market sizing 25:33 - Why GLP-1 users will buy peptides first 27:22 - Ten million potential peptide patients 👀 30:09 - When will legalization happen? 31:09 - Tracking the FDA green list 34:26 - Who wins when peptides go legal? 37:58 - Why Noom won't rush peptide launch 39:33 - Geoff's BPC-157 ski injury recovery 46:42 - Expanding at-home labs past 30 biomarkers 52:47 - Noom IPO coming?! Not financial, legal, or medical advice

$HIMS $LLY $NVO 🚨 BREAKING: Noom is acquiring a 503A pharmacy to prepare for the peptide boom We sat down with Geoff Cook (Noom CEO) to discuss why vertical integration is so important, how large the peptide market is going to be, and the evolving dynamics between telehealth platforms and big pharma A great episode with one of the best CEOs in the game - thanks again, Geoff! 00:00 - Why pharma needs DTC platforms 03:03 - Noom's 90% revenue growth 05:01 - Why Noom bought Tailor Made Compounding 07:29 - The case for vertical integration 08:56 - Compounded GLP-1s aren't going anywhere 16:48 - The Hims-Novo deal 19:08 - Noom's pitch to next-gen pharma 24:24 - Peptide market sizing 25:33 - Why GLP-1 users will buy peptides first 27:22 - Ten million potential peptide patients 👀 30:09 - When will legalization happen? 31:09 - Tracking the FDA green list 34:26 - Who wins when peptides go legal? 37:58 - Why Noom won't rush peptide launch 39:33 - Geoff's BPC-157 ski injury recovery 46:42 - Expanding at-home labs past 30 biomarkers 52:47 - Noom IPO coming?! Not financial, legal, or medical advice

Hims House

55,711 views • 5 months ago

"BPC-157 is the biggest scam I've ever seen. It does absolutely nothing. There's no redeemable value to it." - Martin Shkreli "Why are we going backwards? Why don't we go forwards? What is this urge by the Valley — and I blame the Valley — to go backwards through time and space?" "This is nonsense. This is not science. Science is controlled experiments that are well-done, very carefully documented, and so forth."

"BPC-157 is the biggest scam I've ever seen. It does absolutely nothing. There's no redeemable value to it." - Martin Shkreli "Why are we going backwards? Why don't we go forwards? What is this urge by the Valley — and I blame the Valley — to go backwards through time and space?" "This is nonsense. This is not science. Science is controlled experiments that are well-done, very carefully documented, and so forth."

TBPN

269,287 views • 5 months ago

🚨 THE PEPTIDES BULL CASE FOR $HIMS Jonah Lupton - Founder & CIO of FirstWave Capital We discuss how peptides fit into Jonah's thesis for Hims, Jonah's $30K/year peptide regimen, the possibility of Hims x Lilly, retatrutide, and why he thinks Hims could 10x over the next 10 years 02:34 - How Jonah got into peptides 03:39 - Current Hims position 05:04 - Original Hims thesis in the teens 09:12 - FDA peptide timeline & July meeting 15:03 - Peptides are "80% of the thesis" 18:37 - Jonah's personal peptide stack 26:00 - Spending $30K a year on peptides 28:47 - Black market and WhatsApp China 30:25 - Gray market and the COA problem 31:05 - Why Hims wins on legitimacy 32:36 - Best, not first 32:54 - Frustration with Hims transparency 35:28 - Speed vs the Apple approach 37:45 - Surviving the Novo scare 42:46 - Branded vs compounded future 44:41 - Why Lilly matters more than Novo 50:18 - Valuation and the 2035 model 57:04 - Wrap up and other peptide plays Not financial, legal, or medical advice

🚨 THE PEPTIDES BULL CASE FOR $HIMS Jonah Lupton - Founder & CIO of FirstWave Capital We discuss how peptides fit into Jonah's thesis for Hims, Jonah's $30K/year peptide regimen, the possibility of Hims x Lilly, retatrutide, and why he thinks Hims could 10x over the next 10 years 02:34 - How Jonah got into peptides 03:39 - Current Hims position 05:04 - Original Hims thesis in the teens 09:12 - FDA peptide timeline & July meeting 15:03 - Peptides are "80% of the thesis" 18:37 - Jonah's personal peptide stack 26:00 - Spending $30K a year on peptides 28:47 - Black market and WhatsApp China 30:25 - Gray market and the COA problem 31:05 - Why Hims wins on legitimacy 32:36 - Best, not first 32:54 - Frustration with Hims transparency 35:28 - Speed vs the Apple approach 37:45 - Surviving the Novo scare 42:46 - Branded vs compounded future 44:41 - Why Lilly matters more than Novo 50:18 - Valuation and the 2035 model 57:04 - Wrap up and other peptide plays Not financial, legal, or medical advice

Hims House

124,070 views • 4 months ago

Ahhh, the dichotomy of San Francisco. Where the fentanyl zombies now mingle with the peptide-injecting biohackers and share the same city-sponsored drug testing centers. Our full episode on SF's peptide scene is here with jasmine sun joining Kylie Robison and me. You know what's like putting your finances on the Wolverine Stack? Well, that would be Brex And if you have the things that's actually better than grey market peptides, hit up E1 Ventures 🇺🇸 for your investing needs. Timestamps 00:00:00 Intro 00:04:58 The Gray Market Peptide Boom 00:10:50 Cancer Risks and Biohacking Safety 00:13:36 Inside San Francisco’s Peptide Rave 00:19:43 DIY Ozempic and Kitchen Chemistry 00:23:05 RFK Jr. vs The FDA 00:26:43 Is Biohacking a Chinese Psyop? 00:40:44 Leaving Tech for New Media 00:46:29 The Media vs Tech Disconnect 00:53:58 Defense Tech and American Dynamism 01:00:37 Spy Mania and Visa Nightmares 01:08:20 Why AGI Timelines Are Dead

Ahhh, the dichotomy of San Francisco. Where the fentanyl zombies now mingle with the peptide-injecting biohackers and share the same city-sponsored drug testing centers. Our full episode on SF's peptide scene is here with jasmine sun joining Kylie Robison and me. You know what's like putting your finances on the Wolverine Stack? Well, that would be Brex And if you have the things that's actually better than grey market peptides, hit up E1 Ventures 🇺🇸 for your investing needs. Timestamps 00:00:00 Intro 00:04:58 The Gray Market Peptide Boom 00:10:50 Cancer Risks and Biohacking Safety 00:13:36 Inside San Francisco’s Peptide Rave 00:19:43 DIY Ozempic and Kitchen Chemistry 00:23:05 RFK Jr. vs The FDA 00:26:43 Is Biohacking a Chinese Psyop? 00:40:44 Leaving Tech for New Media 00:46:29 The Media vs Tech Disconnect 00:53:58 Defense Tech and American Dynamism 01:00:37 Spy Mania and Visa Nightmares 01:08:20 Why AGI Timelines Are Dead

Ashlee Vance

34,910 views • 8 months ago

The new Huberman Lab episode is out: Peptides: The Science, Uses & Safety | Dr. Abud Bakri MD 0:00 Abud Bakri 3:33 What are Peptides?, Receptors 6:26 BPC-157, Discovery, Animal Proteins 11:19 BPC-157, Animal Data, Regeneration 12:27 Sponsors: Eight Sleep & Lingo 14:51 BPC-157, Regeneration & Healing, Neurological Effects 19:27 Adverse Events, Clinical Trials & Legality of BPC-157 29:41 GLPs & Compounding Pharmacy; Peptides & Gray Market 35:25 Manufacturing, Compounding Pharmacies, Gray Market, Black Market 41:32 Peptides & Tumor Growth?; Angiogenesis 45:17 Sponsor: AG1 47:01 Pharmaceutical Patents, Clinical Trials for BPC-157, Potential Outcomes 54:19 BPC-157 Healing, Patient Experiences 1:01:22 Physician Counsel, FDA Legality, Malpractice 1:07:25 Pinealon, Epithalon, Discovery; Sleep & Cognitive Performance, Risks 1:18:17 Sponsor: Function 1:19:55 Pineal Age Deterioration, Epithalon, Eye Health 1:29:38 Thymus, Age Shrinkage; Thymosin Alpha-1, Immune Function 1:38:13 TB-500; Pet Health; Thymic Peptide Doses, Thymulin, Zinc 1:49:13 Sponsor: LMNT 1:50:33 GHK-Cu (Copper GHK), Collagen 1:55:32 Illness Recovery, Thymic Score, Tool: Blood Test & Immune Cell Counts 2:04:01 Growth Hormone Secretagogues, Age Decline, Cancer Risk, Insulin 2:15:36 GHK-Cu, Topical Cream, Red Light Therapy 2:20:25 GLPs, Discovery, Physical & Cognitive Long-Term Effects, Fertility 2:33:53 Retatrutide; Drug Patents & Nomenclature 2:39:03 Peptides: Women Reproductive Disorders; TBI, Neurologic Effect; Safe Sources 2:45:34 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Includes paid partnerships.

The new Huberman Lab episode is out: Peptides: The Science, Uses & Safety | Dr. Abud Bakri MD 0:00 Abud Bakri 3:33 What are Peptides?, Receptors 6:26 BPC-157, Discovery, Animal Proteins 11:19 BPC-157, Animal Data, Regeneration 12:27 Sponsors: Eight Sleep & Lingo 14:51 BPC-157, Regeneration & Healing, Neurological Effects 19:27 Adverse Events, Clinical Trials & Legality of BPC-157 29:41 GLPs & Compounding Pharmacy; Peptides & Gray Market 35:25 Manufacturing, Compounding Pharmacies, Gray Market, Black Market 41:32 Peptides & Tumor Growth?; Angiogenesis 45:17 Sponsor: AG1 47:01 Pharmaceutical Patents, Clinical Trials for BPC-157, Potential Outcomes 54:19 BPC-157 Healing, Patient Experiences 1:01:22 Physician Counsel, FDA Legality, Malpractice 1:07:25 Pinealon, Epithalon, Discovery; Sleep & Cognitive Performance, Risks 1:18:17 Sponsor: Function 1:19:55 Pineal Age Deterioration, Epithalon, Eye Health 1:29:38 Thymus, Age Shrinkage; Thymosin Alpha-1, Immune Function 1:38:13 TB-500; Pet Health; Thymic Peptide Doses, Thymulin, Zinc 1:49:13 Sponsor: LMNT 1:50:33 GHK-Cu (Copper GHK), Collagen 1:55:32 Illness Recovery, Thymic Score, Tool: Blood Test & Immune Cell Counts 2:04:01 Growth Hormone Secretagogues, Age Decline, Cancer Risk, Insulin 2:15:36 GHK-Cu, Topical Cream, Red Light Therapy 2:20:25 GLPs, Discovery, Physical & Cognitive Long-Term Effects, Fertility 2:33:53 Retatrutide; Drug Patents & Nomenclature 2:39:03 Peptides: Women Reproductive Disorders; TBI, Neurologic Effect; Safe Sources 2:45:34 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Includes paid partnerships.

Andrew D. Huberman, Ph.D.

2,438,275 views • 3 months ago

since Max Marchione and i last spoke a bunch of things have happened in the world of peptides from RFK's reclassification to huberman posting to people discovering that bodybuilders got there first (bodybuilders drive the culture). so max and i caught up once again to cover all of this. also the mics should be working in this and i think the color is properly graded but yeah just let me know in the comments if something is off. i know you guys will. cheers 👍 01:21 - RFK peptide reclassification 03:55 - Why are peptides are popular now 05:00 - Bodybuilders did it first 08:50 - Andrew D. Huberman, Ph.D. on a16z 13:25 - Black market vs grey market vs compounding pharmacy 16:35 - The stages of peptide legalization 19:47 - The genie is out of the bottle 23:40 - TJ Parker⚡️ reaction 26:10 - asparagoid reaction 29:29 - Short term vs long term risk tradeoffs

since Max Marchione and i last spoke a bunch of things have happened in the world of peptides from RFK's reclassification to huberman posting to people discovering that bodybuilders got there first (bodybuilders drive the culture). so max and i caught up once again to cover all of this. also the mics should be working in this and i think the color is properly graded but yeah just let me know in the comments if something is off. i know you guys will. cheers 👍 01:21 - RFK peptide reclassification 03:55 - Why are peptides are popular now 05:00 - Bodybuilders did it first 08:50 - Andrew D. Huberman, Ph.D. on a16z 13:25 - Black market vs grey market vs compounding pharmacy 16:35 - The stages of peptide legalization 19:47 - The genie is out of the bottle 23:40 - TJ Parker⚡️ reaction 26:10 - asparagoid reaction 29:29 - Short term vs long term risk tradeoffs

atlas

87,837 views • 6 months ago

YOU ALL GONNA BE EXCITED WITH THIS ONE, YOU CAN NOW GET A RELIABLE source of PEPTIDES FROM MYSELF FOLLOW SUPREME PEPTIDES AND WATCH THIS GROW, PEOPLE KNOW THEY CAN TRUST ME. BENEFITS BELOW ⬇️ Peptides are short chains of amino acids that act as signaling molecules in the body. Different peptides have very different effects, so the benefits depend entirely on which peptide you’re referring to. Here are some of the most commonly discussed peptide categories and their potential benefits: Healing and Recovery * BPC-157 – Often promoted for tendon, ligament, muscle, and gut healing. * TB-500 (Thymosin Beta-4 fragment) – May support tissue repair and reduce recovery time after injury. * Potential benefits: * Faster recovery from injuries * Improved wound healing * Reduced inflammation (evidence in humans is limited) Muscle Growth and Performance * CJC-1295 and Ipamorelin – Stimulate the body’s release of growth hormone. * Potential benefits: * Increased lean muscle mass * Better recovery after exercise * Improved sleep * Possible reduction in body fat Weight Loss * Tirzepatide and Semaglutide * Potential benefits: * Reduced appetite * Significant weight loss * Improved blood sugar control in people with diabetes Skin and Anti-Ageing * GHK-Cu (Copper Peptide) * Potential benefits: * Improved skin elasticity * Reduced appearance of fine lines * May promote hair growth * Supports wound healing Sexual Health * PT-141 (Bremelanotide) * Potential benefits: * Increased sexual desire in some people * Used for certain forms of low sexual desire Immune Function * Thymosin Alpha-1 * Potential benefits: * Supports immune system function * Studied in certain infections and cancers Are peptides safe? It depends on the peptide and how it’s used.

YOU ALL GONNA BE EXCITED WITH THIS ONE, YOU CAN NOW GET A RELIABLE source of PEPTIDES FROM MYSELF FOLLOW SUPREME PEPTIDES AND WATCH THIS GROW, PEOPLE KNOW THEY CAN TRUST ME. BENEFITS BELOW ⬇️ Peptides are short chains of amino acids that act as signaling molecules in the body. Different peptides have very different effects, so the benefits depend entirely on which peptide you’re referring to. Here are some of the most commonly discussed peptide categories and their potential benefits: Healing and Recovery * BPC-157 – Often promoted for tendon, ligament, muscle, and gut healing. * TB-500 (Thymosin Beta-4 fragment) – May support tissue repair and reduce recovery time after injury. * Potential benefits: * Faster recovery from injuries * Improved wound healing * Reduced inflammation (evidence in humans is limited) Muscle Growth and Performance * CJC-1295 and Ipamorelin – Stimulate the body’s release of growth hormone. * Potential benefits: * Increased lean muscle mass * Better recovery after exercise * Improved sleep * Possible reduction in body fat Weight Loss * Tirzepatide and Semaglutide * Potential benefits: * Reduced appetite * Significant weight loss * Improved blood sugar control in people with diabetes Skin and Anti-Ageing * GHK-Cu (Copper Peptide) * Potential benefits: * Improved skin elasticity * Reduced appearance of fine lines * May promote hair growth * Supports wound healing Sexual Health * PT-141 (Bremelanotide) * Potential benefits: * Increased sexual desire in some people * Used for certain forms of low sexual desire Immune Function * Thymosin Alpha-1 * Potential benefits: * Supports immune system function * Studied in certain infections and cancers Are peptides safe? It depends on the peptide and how it’s used.

Anthony Fowler

28,226 views • 2 months ago

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice

Hims House

85,085 views • 2 months ago

.Martin Shkreli says taking retatrutide is the "worst risk-reward decision you could possibly make": "The people that are taking peptides, and have these 'peptide stacks,' are mostly people in SF, maybe in NY. They're very wealthy people. They don't know what the rest of the world looks like." "Nobody else in Middle America is excited to do this. It's not normal to inject yourself with things. This isn't a thing everyone should be doing." "What is your upside to taking illegally manufactured retatrutide — you can't verify it, etc. — versus just taking Ozempic?"

.Martin Shkreli says taking retatrutide is the "worst risk-reward decision you could possibly make": "The people that are taking peptides, and have these 'peptide stacks,' are mostly people in SF, maybe in NY. They're very wealthy people. They don't know what the rest of the world looks like." "Nobody else in Middle America is excited to do this. It's not normal to inject yourself with things. This isn't a thing everyone should be doing." "What is your upside to taking illegally manufactured retatrutide — you can't verify it, etc. — versus just taking Ozempic?"

TBPN

281,458 views • 5 months ago

🚨 Emergency Pod 🚨 RFK announces peptide reclassification! what does this all mean? will the technology brothers finally be able to source peptides not of the sketchy chinese kind? is this legalization or a different thing? are the technology brothers going too far with peptides? Max Marchione and i covered all of this and more 00:00 - RFK announce peptide reclassification again 02:31 - Secretary Kennedy reaction 06:18 - What peptides are we likely to see be legalized? 07:41 - Could this affect what peptides are banned or approved by WADA? 08:32 - Are peptides bigger than AI? 09:27 - Do you think it’s a one-off reclassification or will there be a continuous review of peptides from now on? 12:16 - Should I get bloodwork before starting a peptide protocol? 13:27 - What does this mean for Superpower? Will you be the first on the market for peptides? 15:56 - How will you compete with $HIMS? 16:32 - What’s your stack? 18:30 - The tech bros are taking it too far

🚨 Emergency Pod 🚨 RFK announces peptide reclassification! what does this all mean? will the technology brothers finally be able to source peptides not of the sketchy chinese kind? is this legalization or a different thing? are the technology brothers going too far with peptides? Max Marchione and i covered all of this and more 00:00 - RFK announce peptide reclassification again 02:31 - Secretary Kennedy reaction 06:18 - What peptides are we likely to see be legalized? 07:41 - Could this affect what peptides are banned or approved by WADA? 08:32 - Are peptides bigger than AI? 09:27 - Do you think it’s a one-off reclassification or will there be a continuous review of peptides from now on? 12:16 - Should I get bloodwork before starting a peptide protocol? 13:27 - What does this mean for Superpower? Will you be the first on the market for peptides? 15:56 - How will you compete with $HIMS? 16:32 - What’s your stack? 18:30 - The tech bros are taking it too far

atlas

44,226 views • 5 months ago